219 related articles for article (PubMed ID: 18311478)
1. Mechanistic analysis of chemical permeation enhancers for oral drug delivery.
Whitehead K; Mitragotri S
Pharm Res; 2008 Jun; 25(6):1412-9. PubMed ID: 18311478
[TBL] [Abstract][Full Text] [Related]
2. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
Gupta V; Hwang BH; Doshi N; Mitragotri S
J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
[TBL] [Abstract][Full Text] [Related]
3. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
4. Safe and effective permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
Pharm Res; 2008 Aug; 25(8):1782-8. PubMed ID: 18058001
[TBL] [Abstract][Full Text] [Related]
5. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
7. In silico modelling of permeation enhancement potency in Caco-2 monolayers based on molecular descriptors and random forest.
Welling SH; Clemmensen LK; Buckley ST; Hovgaard L; Brockhoff PB; Refsgaard HH
Eur J Pharm Biopharm; 2015 Aug; 94():152-9. PubMed ID: 26004819
[TBL] [Abstract][Full Text] [Related]
8. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
9. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
10. The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.
Lamson NG; Cusimano G; Suri K; Zhang A; Whitehead KA
Mol Pharm; 2016 Feb; 13(2):578-85. PubMed ID: 26730955
[TBL] [Abstract][Full Text] [Related]
11. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments.
Larsen NW; Kostrikov S; Hansen MB; Hjørringgaard CU; Larsen NB; Andresen TL; Kristensen K
Int J Pharm; 2024 Apr; 654():123957. PubMed ID: 38430950
[TBL] [Abstract][Full Text] [Related]
12. Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.
Fein KC; Lamson NG; Whitehead KA
Pharm Res; 2017 Jun; 34(6):1320-1329. PubMed ID: 28374339
[TBL] [Abstract][Full Text] [Related]
13. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
14. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
Stuettgen V; Brayden DJ
AAPS J; 2020 Jan; 22(2):33. PubMed ID: 31989362
[TBL] [Abstract][Full Text] [Related]
15. Intestinal permeation enhancers for oral peptide delivery.
Maher S; Mrsny RJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
17. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
18. Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.
Dahlgren D; Olander T; Sjöblom M; Hedeland M; Lennernäs H
Acta Pharm Sin B; 2021 Jun; 11(6):1667-1675. PubMed ID: 34221875
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Intestinal Absorption of a Model Macromolecule via the Paracellular Pathway using E-Cadherin Peptides.
Dening TJ; Siahaan TJ; Hageman MJ
J Pharm Sci; 2021 May; 110(5):2139-2148. PubMed ID: 33359310
[TBL] [Abstract][Full Text] [Related]
20. Dodecylmaltoside Modulates Bicellular Tight Junction Contacts To Promote Enhanced Permeability.
Gradauer K; Iida M; Watari A; Kataoka M; Yamashita S; Kondoh M; Buckley ST
Mol Pharm; 2017 Dec; 14(12):4734-4740. PubMed ID: 28985076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
